Vudalimab Biosimilar - Research Grade,ichor.bio,ICH5113

Detects human PD-1 and human CTLA-4

Host

CHO Cells

Reactivity

Human

Platform ID

BAB077905559

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

ichor.bio

Contact

Tel:
Fax:

Email:

[email protected]

Product Specifications
Scientific Background

Specifications

NameVudalimab Biosimilar - Research Grade
Cat. No.ICH5113
HostCHO Cells
IsotypeHuman IgG1 (N208D/E233P/L234V/L235A/G236Del/S267K/Q295E/L368D/K370S/N384D/Q418E/N421D/M428L/N434S)-Kappa
ReactivityHuman
Concentration5mg/ml
TargetPD-1 + CTLA-4
Purity>90% by SDS-PAGE
Endotoxin Level<1EU/mg Determined by LAL gel clotting assay
ShippingBlue ice
FormulationICH3002
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only

Scientific Background

Uses the same sequence as the therapeutic antibody Vudalimab

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.